General review of billing problem based visits and annual exam visits in primary care clinic

The rest of the diabetes didactic, reviewing pharmacologic management of diabetes in more detail, focusing on insulin primarily with brief review of GLP1 and SGLT2 administration.

Reviewing screening recommendations and how to diagnose diabetes, end-organ effect monitoring as well as a general overview of pharmacologic therapy.

Quickly reviewing the components of an annual exam as well as general review of screening recommendations for cancers, metabolic disease, STIs and vaccinations.

Reviewing screening and diagnosis recommendations for depression, first line treatment and adjunctive pharmacotherapy and non-pharmacological interventions, including medication titration and anticipatory guidance as well as quick review of addressing suicidal intention, passive and active, in the clinic

General overview of the categories of hypertension, other contributors to elevated blood pressure to assess for and both non-pharmacological and pharmacological treatment options for stage 1 and stage 2 hypertension as per 2025 AHA/ACC guidelines.

Defining hyperlipidemia and reviewing the algorithms for risk assessment and management of hyperlipidemia for primary prevention in patients ages 30-79 with LDL 70-189 and patients with diabetes, including statin management per the updated 2026 ACC/AHA guidelines.

Reviewing screening recommendations and diagnostic evaluation of new outpatient hepatitis B and C cases and general treatment, anticipated side effects and post-treatment monitoring for hepatitis B and C.